Metrics to compare | VDP | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipVDPPeersSector | |
|---|---|---|---|---|
P/E Ratio | 13.1x | 13.6x | −0.3x | |
PEG Ratio | −1.16 | 0.10 | 0.00 | |
Price/Book | 1.1x | 1.2x | 2.6x | |
Price / LTM Sales | 0.8x | 1.8x | 3.1x | |
Upside (Analyst Target) | - | 34.1% | 48.3% | |
Fair Value Upside | Unlock | 25.1% | 6.7% | Unlock |
Vidipha Central Pharmaceutical Joint Stock Company produces and sells pharmaceutical products in Vietnam. It offers analgesics, antipyretics, gastrointestinal agents, antidiabetic agents, antibiotics, antivirals, antifungals, antihistamines, anti-allergic agents, respiratory agents, cardiovascular, neurological, antihypertensive agents, diuretics, vitamins, minerals, antiseptics, and others. The company also engages in the hotel and real estate businesses; and provision of drug storage and testing, and technology transfer consulting services. In addition, it produces, trades, imports, and exports medical herbs, raw materials, chemicals, cosmetics, food, medical equipment, and supplies. The company distributes its products through pharmaceutical companies, hospitals, and pharmacies. It also exports its products. Vidipha Central Pharmaceutical Joint Stock Company was founded in 2003 and is headquartered in Ho Chi Minh City, Vietnam.